Found 155 matching trials
PSMA-RLT in Biochemically Recurrent PCa PHASE2 Prospective single-center one-arm phase II study in patients with prostate ...
Show More Location
Medical University of Vienna
Learn More & Join Trial
NEPC Study: An Exploratory Safety and Efficacy Study With PSMA, SSTR2 and GRPR Targeted Radioligand Therapy in Metastatic Neuroendocrine Prostate Cancer. PHASE1 The purpose of this study is to evaluate the change in the expression of tr...
Show More Status
Active Not Recruiting
Location
Nebraska Cancer Specialists
Learn More & Join Trial
Phase 2 Randomized Trial of Flexible Dosing Schedule of 177Lu-PSMA-617 for the Treatment of Metastatic Castration-Resistant Prostate Cancer (FLEX-MRT) PHASE2 In advanced metastatic castration resistant prostate cancer (mCRPC) progres...
Show More Location
UCLA / Jonsson Comprehensive Cancer Center
Learn More & Join Trial
Study of 177Lu-PSMA-617 In Metastatic Castrate-Resistant Prostate Cancer in Japan PHASE2 The purpose of this study is to assess the efficacy, tolerability, safety, ...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
177^Lu-PSMA-617 in Combination With Sipuleucel-T for the Treatment of Metastatic Castration-Resistant Prostate Cancer PHASE1 This phase I trial compares the effect of lutetium Lu 177 (177\^Lu)-prostat...
Show More Location
City of Hope Medical Center
Learn More & Join Trial
Mechanisms of Resistance to PSMA Radioligand Therapy N/A This is a multicenter, correlative study to existing Lutetium based prostat...
Show More Location
University of California, Los Angeles
Learn More & Join Trial
Phase Ib Trial of 177Lu-PSMA-I&T Therapy in Combination With Olaparib and Pembrolizumab in Patients With Metastatic Castration Resistant Prostate Cancer PHASE1 This phase 1b trial is designed to evaluate the safety and tolerability of ...
Show More Location
Peter MacCallum Cancer Centre
Learn More & Join Trial
Study to Assess [177Lu]Lu-PSMA-R2 (AAA602) and [225Ac]Ac-PSMA-R2 (AAA802) in Participants With PSMA-positive HRLPC PHASE1 The purpose of this trial is to learn more about the effects of AAA602 and ...
Show More Location
Multiple Locations
Learn More & Join Trial
68Ga-PSMA-11 PET/CT Screening Prior to 177Lu-PSMA-617 Therapy for Patients With Metastatic Castrate Resistant Prostate Cancer PHASE3 This phase III study provides access to 68Ga-PSMA-11 positron emission tomo...
Show More Location
Mayo Clinic in Rochester
Learn More & Join Trial
177Lu-LNC1011 in Patients with Metastatic Castration-resistant Prostate Cancer PHASE1 This study employed an open-label, non-randomized design, representing the ...
Show More Location
Peking Union Medical College Hospital
Learn More & Join Trial